Literature DB >> 30460391

Carcinogenesis: the cancer cell-mast cell connection.

Maria-Angeles Aller1, Ana Arias2, Jose-Ignacio Arias3, Jaime Arias4.   

Abstract

BACKGROUND: In mammals, inflammation is required for wound repair and tumorigenesis. However, the events that lead to inflammation, particularly in non-healing wounds and cancer, are only partly understood.
FINDINGS: Mast cells, due to their great plasticity, could orchestrate the inflammatory responses inducing the expression of extraembryonic programs of normal and pathological tissue formation. This heterogeneity of mast cells could allow a microenvironment to be recreated similar to the extraembryonic structures, i.e., amnion and yolk sac, which are needed for embryonic development. Mast cells could provide a framework for understanding the connection between inflammation and tumor growth, invasion and metastasis. In this way, the mast cells could express inflammatory phenotypes, which would enable the cancer stem cells to develop. Thus, the cancer cell uses mast cells to express the extraembryonic functions that are needed to allow the cancer stem cell to proliferate and invade. If so, then by using this appropriate inflammatory interstitial microenvironment, a cancer stem cell can reach maximum levels of growth and invasion inside the host.
CONCLUSION: Therefore, the comparison of tumors with wounds that do not heal would be supported since both pathological processes use extraembryonic mechanisms by mast cells. The adoption of these mechanisms warrants tumor survival in an embryonic-like state.

Entities:  

Keywords:  Amniotic; Cancer; Chronic inflammation; Ischemia–reperfusion; Mast cell; Vitelline

Mesh:

Year:  2018        PMID: 30460391     DOI: 10.1007/s00011-018-1201-4

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  154 in total

Review 1.  Fibroblasts regulate the switch from acute resolving to chronic persistent inflammation.

Authors:  C D Buckley; D Pilling; J M Lord; A N Akbar; D Scheel-Toellner; M Salmon
Journal:  Trends Immunol       Date:  2001-04       Impact factor: 16.687

Review 2.  Radical causes of cancer.

Authors:  S Perwez Hussain; Lorne J Hofseth; Curtis C Harris
Journal:  Nat Rev Cancer       Date:  2003-04       Impact factor: 60.716

Review 3.  Posttraumatic inflammation is a complex response based on the pathological expression of the nervous, immune, and endocrine functional systems.

Authors:  M A Aller; J L Arias; M P Nava; J Arias
Journal:  Exp Biol Med (Maywood)       Date:  2004-02

4.  The use of inflammation by tumor cells.

Authors:  Jose-Ignacio Arias; María-Angeles Aller; Jaime Arias
Journal:  Cancer       Date:  2005-07-15       Impact factor: 6.860

Review 5.  Mast cells in the development of adaptive immune responses.

Authors:  Stephen J Galli; Susumu Nakae; Mindy Tsai
Journal:  Nat Immunol       Date:  2005-02       Impact factor: 25.606

Review 6.  Investigating hypoxic tumor physiology through gene expression patterns.

Authors:  Nicholas C Denko; Lucrezia A Fontana; Karen M Hudson; Patrick D Sutphin; Soumya Raychaudhuri; Russ Altman; Amato J Giaccia
Journal:  Oncogene       Date:  2003-09-01       Impact factor: 9.867

Review 7.  Wound healing: an overview of acute, fibrotic and delayed healing.

Authors:  Robert F Diegelmann; Melissa C Evans
Journal:  Front Biosci       Date:  2004-01-01

Review 8.  Inflammation and cancer.

Authors:  Lisa M Coussens; Zena Werb
Journal:  Nature       Date:  2002 Dec 19-26       Impact factor: 49.962

9.  Angiogenesis in human cancer: implications in cancer therapy.

Authors:  Aristotle Bamias; Meletios A. Dimopoulos
Journal:  Eur J Intern Med       Date:  2003-12       Impact factor: 4.487

Review 10.  Inflammatory cells and cancer: think different!

Authors:  L M Coussens; Z Werb
Journal:  J Exp Med       Date:  2001-03-19       Impact factor: 14.307

View more
  5 in total

1.  PDK4 Constitutes a Novel Prognostic Biomarker and Therapeutic Target in Gastric Cancer.

Authors:  Zimu Zhang; Shiyuan Han; Siwen Ouyang; Ziyang Zeng; Zhen Liu; Juan Sun; Weiming Kang
Journal:  Diagnostics (Basel)       Date:  2022-04-27

2.  A comprehensive prognostic and immune analysis of enhancer RNA identifies IGFBP7-AS1 as a novel prognostic biomarker in Uterine Corpus Endometrial Carcinoma.

Authors:  Jinhui Liu; Jian Yin; Yuanyuan Wang; Lixin Cai; Rui Geng; Mulong Du; Zihang Zhong; Senmiao Ni; Xiaohao Huang; Hao Yu; Jianling Bai
Journal:  Biol Proced Online       Date:  2022-07-15       Impact factor: 7.717

3.  Immune microenvironment composition in non-small cell lung cancer and its association with survival.

Authors:  Menno Tamminga; Thijo Jeroen N Hiltermann; Ed Schuuring; Wim Timens; Rudolf Sn Fehrmann; Harry Jm Groen
Journal:  Clin Transl Immunology       Date:  2020-06-12

4.  Mast Cells Are Directly Activated by Cancer Cell-Derived Extracellular Vesicles by a CD73- and Adenosine-Dependent Mechanism.

Authors:  Yaara Gorzalczany; Ofer Merimsky; Ronit Sagi-Eisenberg
Journal:  Transl Oncol       Date:  2019-09-04       Impact factor: 4.243

Review 5.  Modern Imaging Technologies of Mast Cells for Biology and Medicine (Review).

Authors:  I P Grigorev; D E Korzhevskii
Journal:  Sovrem Tekhnologii Med       Date:  2021-08-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.